Harm reduction in the hospital: An overdose prevention site (OPS) at a Canadian hospital
- PMID: 36063622
- PMCID: PMC9970047
- DOI: 10.1016/j.drugalcdep.2022.109608
Harm reduction in the hospital: An overdose prevention site (OPS) at a Canadian hospital
Abstract
Background: Substance use management in hospitals can be challenging. In response, a Canadian hospital opened an overdose prevention site (OPS) where community members and hospital inpatients can inject pre-obtained illicit drugs under supervision. This study aims to: (1) describe program utilization patterns; (2) characterize OPS visits; and (3) evaluate overdose events and related outcomes.
Methods: A retrospective chart review was completed at one hospital in Vancouver, Canada. All community members and hospital inpatients who visited the OPS between May 2018 and July 2019 were included. Client measures included: hospital inpatient status, use of intravenous access line for drug injection, and substances used. Program measures included: number of visits (daily/monthly), overdose (fatal/non-fatal) events and overdose-related outcomes.
Results: Overall, 11,673 OPS visits were recorded. Monthly visits increased from 306 to 1198 between May 2018 and July 2019 respectively. On average, 26 visits occurred daily. Among all visits, 20% reported being a hospital inpatient, and 5% reported using a hospital intravenous access line for drug injection. Opioids (56%) and stimulants (24%) were the most common substances used. Overall 39 overdose events occurred - 82% required naloxone reversal, 28% required transfer to the hospital's emergency department and none were fatal. Overdose events were more common among hospital inpatients compared to community clients (6.6 vs 2.2 per 1000 visits respectively; p value = 0.046).
Conclusions: This unique OPS is an example of a hospital-based harm reduction initiative. Use of the site increased over time among both groups with no fatal overdose events occurring.
Keywords: Harm reduction; Hospital; Injection drugs; Overdose prevention; Supervised consumption.
Copyright © 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflict of interest Evan Wood is the Chief Medical Officer of Numinus Wellness a mental health company focussed on psychedelic medicines.
Figures





Similar articles
-
Implementation of a nurse-led overdose prevention site in a hospital setting: lessons learned from St. Paul's Hospital, Vancouver, Canada.Harm Reduct J. 2022 Feb 5;19(1):13. doi: 10.1186/s12954-022-00596-7. Harm Reduct J. 2022. PMID: 35120536 Free PMC article.
-
Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018-2022.Int J Drug Policy. 2025 Mar;137:104711. doi: 10.1016/j.drugpo.2025.104711. Epub 2025 Jan 21. Int J Drug Policy. 2025. PMID: 39842392
-
(Re)situating expertise in community-based overdose response: Insights from an ethnographic study of overdose prevention sites (OPS) in Vancouver, Canada.Int J Drug Policy. 2023 Jan;111:103929. doi: 10.1016/j.drugpo.2022.103929. Epub 2022 Dec 16. Int J Drug Policy. 2023. PMID: 36529032 Free PMC article.
-
Between Emergency Department Visits: The Role of Harm Reduction Programs in Mitigating the Harms Associated With Injection Drug Use.Ann Emerg Med. 2021 May;77(5):479-492. doi: 10.1016/j.annemergmed.2020.11.008. Epub 2021 Feb 10. Ann Emerg Med. 2021. PMID: 33579588 Review.
-
Overdosevarslingssystemer – en kartleggingsoversikt med maskinlæring.Nordisk Alkohol Nark. 2023 Oct;40(5):443-462. doi: 10.1177/14550725221143180. Epub 2023 Sep 6. Nordisk Alkohol Nark. 2023. PMID: 37969899 Free PMC article. Review. Norwegian.
Cited by
-
Perceived need for care and stigma experiences among individuals with methamphetamine-related admissions to inpatient mental health wards.Harm Reduct J. 2023 Aug 2;20(1):104. doi: 10.1186/s12954-023-00827-5. Harm Reduct J. 2023. PMID: 37533062 Free PMC article.
-
Perspectives of healthcare workers on the integration of overdose detection technologies in acute care settings.Addict Sci Clin Pract. 2024 Jan 12;19(1):4. doi: 10.1186/s13722-023-00433-7. Addict Sci Clin Pract. 2024. PMID: 38217056 Free PMC article.
-
Perspectives of patients who inject drugs on a needle and syringe program at a large acute care hospital.PLoS One. 2024 Feb 15;19(2):e0297584. doi: 10.1371/journal.pone.0297584. eCollection 2024. PLoS One. 2024. PMID: 38359010 Free PMC article.
-
Opioid-related deaths during hospital admissions or shortly after discharge in the United Kingdom: A thematic framework analysis of coroner reports.PLoS One. 2023 Apr 19;18(4):e0283549. doi: 10.1371/journal.pone.0283549. eCollection 2023. PLoS One. 2023. PMID: 37075021 Free PMC article.
-
"Every Time I Go in There, It Gives Me Time to Reflect": A Qualitative Study of Patient Perspectives on Substance Use, Medications for Opioid Use Disorder, and Harm Reduction Following Hospitalization for Serious Injection-Related Infection.Open Forum Infect Dis. 2025 Apr 3;12(5):ofaf201. doi: 10.1093/ofid/ofaf201. eCollection 2025 May. Open Forum Infect Dis. 2025. PMID: 40352630 Free PMC article.
References
-
- Chan ACH, Palepu A, Guh DP, Sun H, Schechter MT, O’Shaughnessy MV, et al.: HIV-positive injection drug users who leave the hospitals against medical advice. The mitigating role of methadone and social support. JAIDS 2004; 35: pp. 56–59. - PubMed
-
- Daigre C, Comin M, Rodriguez-Cintas L, et al.: Users’ perception of a harm reduction program in an outpatient drug dependency treatment center. Gac. Sanit 2010; 24: pp. 446–452. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources